Claus Elsborg Olesen
Gründer bei INITIATOR PHARMA A/S
Aktive Positionen von Claus Elsborg Olesen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INITIATOR PHARMA A/S | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Vorstandsvorsitzender | 01.01.2016 | - | |
| Gründer | 01.01.2016 | - | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Vorstandsvorsitzender | 01.01.2018 | - |
| Gründer | 01.01.2018 | - |
Karriereverlauf von Claus Elsborg Olesen
Ehemalige bekannte Positionen von Claus Elsborg Olesen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Direktor/Vorstandsmitglied | 07.05.2015 | - |
| Gründer | 07.05.2015 | - | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Gründer | 01.01.2009 | - |
Ausbildung von Claus Elsborg Olesen
| University of Aarhus | Doctorate Degree |
Statistik
International
| Dänemark | 6 |
Operativ
| Founder | 4 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INITIATOR PHARMA A/S | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Health Technology |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Health Technology |
- Börse
- Insiders
- Claus Elsborg Olesen
- Erfahrung
